Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort von Epaillard, N., Lusque, A., Jacot, W., Mailliez, A., Bachelot, T., Arnedos, M., Le Du, F., Brain, E., Ferrero, J.M., Massard, V., Desmoulins, I., Mouret-Reynier, M.A., Levy, C., Gonçalves, A., Leheurteur, M., Petit, T., Filleron, T., Bosquet, L., Pistilli, B., Frenel, J.S.

Volltext

2331P Interest of next generation sequencing (NGS) for integrated molecular diagnosis of HER2-low breast cancer von Merlin, J.L., Husson, M., Sahki, N., Gilson, P., Leroux, A., Massard, V., Harlé, A.

Volltext

An unusual presentation of a pelvic textiloma mimicking a tumor von Kadi, R, Massard, V, Houte, K Vanden, Gerard, C, Divano, L, Jani, J, Laureys, M, Najar, E, Cannie, M

Volltext

1814P First real-life data on [177Lu]Lu-PSMA-617: Descriptive analysis on the largest metastatic castration-resistant prostate cancer (mCRPC) cohort treated in early access in Fran... von Giraudet, A-L., Olivier, P., Massard, V., Flechon, A., Girault, S., Abadie Lacourtoisie, S., Somme, F., Barthelemy, P., Bailly, C., Viala, C., Godbert, Y., Roubaud, G.

Volltext

1627P Long survivors after androgen deprivation therapy (ADT) with or without docetaxel for metastatic castration-sensitive prostate cancer (mCSPC): Long-term follow-up of GETUG-15 von Blanchet-Deverly, S., Fizazi, K., Oudard, S., Gravis, G., Boughalem, E., Borchiellini, D., Foulon, S., Peyre Pradat, F., Beuzeboc, P., Mourey, L., Laguerre, B., Jacobs, M., Tosi, D., Priou, F., Sfumato, P., Massard, V.

Volltext

69P Transferrin saturation shows high prevalence of iron deficiency in cancer patients under adjuvant and neo-adjuvant treatment von Luporsi-Gely, E., Turpin, A., Massard, V., Morin, S., Simon, H., Ruppert, A-M., Belarbia, S., Chauffert, B., Lopez, A., Carnot, A.

Volltext

Transferrin saturation shows high prevalence of iron deficiency in cancer patients under adjuvant and neo-adjuvant treatment von Luporsi-Gely, E., Turpin, A., Massard, V., Morin, S., Simon, H., Ruppert, A-M., Belarbia, S., Chauffert, Bruno, Lopez, A., Carnot, A.

Volltext

Abstract OT1-03-02: CICLADES: Monitoring of ESR1 , PIK3CA and AKT1 ctDNA mutations during real-life follow-up of patients with advanced breast cancer treated with endocrine therapy von Massard, V, Uwer, L, Salleron, J, Deblock, M, Kieffer, A, Rios, M, Gilson, P, Lesur, A, Harle, A, Merlin, JL

Volltext

160P CICLADES-CE study: Genomic signatures detected in DNA from FFPE samples of patients with advanced or metastatic breast cancers treated with anti-aromatase and CDK4/6 inhibitor... von Betz, M., Husson, M., Filhine-Tresarrieu, P., Dardare, J., Witz, A., Rouyer, M., Demange, J., Tosti, P., Gilson, P., Merlin, J.L., Massard, V., Harlé, A.

Volltext

204P Clinical features predictive of never-progressive disease to first-line anti-HER2 therapy: Real-world data from the ESME national cohort von Grinda, T., Carton, M., Morganti, S., Mailliez, A., Levy, C., Petit, T., Bachelot, T., Arnedos, M., Dieras, V.C., Massard, V., Dalenc, F., Desmoulins, I., Gonçalves, A., Bailleux, C., Frenel, J-S., Bosquet, L., Delaloge, S., Lin, N.U., Jacot, W., Parsons, H.A.

Volltext

000348 MAGNETIC RESONANCE IMAGING IN ENDOMETRIALCANCER: A SINGLE CENTER EXPERIENCE von Massard, V., Simon, P., Noel, J. C., Coppens, E., Buxant, F.

Volltext

Prognosis and survival of patients with T1a breast carcinoma: a single center retrospective study von Massard, V, MacGrogan, G, Debled, M, Tunon de Lara, C, Mauriac, L

Volltext

217P Incidence and outcome of brain and/or leptomeningeal metastatic disease in HER2-low breast cancer in the French ESME cohort von Epaillard, N., Lusque, A., Jacot, W., Mailliez, A., Bachelot, T., Arnedos, M., Dieras, V.C., Brain, E.G.C., Ferrero, J-M., Massard, V., Desmoulins, I., Mouret, M-A., Levy, C., Gonçalves, A., Leheurteur, M., Petit, T., Filleron, T., Bosquet, L., Pistilli, B., Frenel, J-S.

Volltext

Analyse descriptive de la plus grande cohorte mondiale de patients atteints de cancer de la prostate résistant à la castration métastatique (CPRCM) traités en accès précoce par [17... von Barthelemy, P., Somme, F., Olivier, P., Massard, V., Godbert, Y., Roubaud, G., Girault, S., Abadie-Lacourtoisie, S., Bailly, C., Viala, C., Flechon, A., Giraudet, A.

Volltext

Analyse descriptive de la plus grande cohorte mondiale de patients atteints de CPRCm traités en accès précoce par [177Lu]Lu-PSMA-617 von Bailly, C., Barthelemy, P., Somme, F., Olivier, P., Massard, V., Godbert, Y., Roubaud, G., Girault, S., Abadie, S., Fléchon, A., Giraudet, A.L., Viala, C.

Volltext

Prognosis and survival of patients with T1a breast carcinoma: A single center retrospective study von Massard, V., MacGrogan, G., Debled, M., de Lara, C. Tunon, Mauriac, L.

Volltext

Rapid test device with multiple different diagnostic methods von SILVA ALFREDO FERNANDO DOMENICO, STAINER, MATTHEW, TILLAPUAZPIROS, JACK, MASSARD D V L M, ESTEVES FERREIRA, MARIA

Volltext bestellen

Monitoring Well Screen Influences on Direct Flowmeter Measurements von Kerfoot, William B., Massard, Victoria A.

Volltext

Immune-related adverse events with immune checkpoint blockade: a comprehensive review von Michot, J.M, Bigenwald, C, Champiat, S, Collins, M, Carbonnel, F, Postel-Vinay, S, Berdelou, A, Varga, A, Bahleda, R, Hollebecque, A, Massard, C, Fuerea, A, Ribrag, V, Gazzah, A, Armand, J.P, Amellal, N, Angevin, E, Noel, N, Boutros, C, Mateus, C, Robert, C, Soria, J.C, Marabelle, A, Lambotte, O

Volltext

Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study von McDermott, David F, Sosman, Jeffrey A, Sznol, Mario, Massard, Christophe, Gordon, Michael S, Hamid, Omid, Powderly, John D, Infante, Jeffrey R, Fassò, Marcella, Wang, Yan V, Zou, Wei, Hegde, Priti S, Fine, Gregg D, Powles, Thomas

Volltext